Glenmark Pharmaceuticals
GLENMARK.NS
#2222
Rank
C$11.56 B
Marketcap
C$40.98
Share price
1.51%
Change (1 day)
39.77%
Change (1 year)

P/S ratio for Glenmark Pharmaceuticals (GLENMARK.NS)

P/S ratio as of November 2026 (TTM): 4.79

According to Glenmark Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 7.17. At the end of 2026 the company had a P/S ratio of 4.06.

P/S ratio history for Glenmark Pharmaceuticals from 2012 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20264.0615.6%
20253.513.11%
20243.4169.41%
20232.01104.45%
20220.9832-20.19%
20211.23-6.99%
20201.3240.14%
20190.9452-53.8%
20182.0510.42%
20171.85-34.62%
20162.83-21.36%
20153.6015.18%
20143.1326.56%
20132.47-16.01%
20122.94